A detailed history of Shoker Investment Counsel, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Shoker Investment Counsel, Inc. holds 24,039 shares of ABBV stock, worth $4.67 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
24,039
Previous 24,918 3.53%
Holding current value
$4.67 Million
Previous $4.54 Million 9.12%
% of portfolio
1.46%
Previous 1.62%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $136,060 - $158,888
-879 Reduced 3.53%
24,039 $4.12 Million
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $22,694 - $25,858
142 Added 0.57%
24,918 $4.54 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $15,136 - $17,046
110 Added 0.45%
24,776 $3.84 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $13,893 - $16,083
-104 Reduced 0.42%
24,666 $3.68 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $927 - $1,154
-7 Reduced 0.03%
24,770 $3.34 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $3,036 - $3,497
-21 Reduced 0.08%
24,777 $3.95 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $120,329 - $144,306
-870 Reduced 3.39%
24,798 $4.01 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $67,641 - $77,580
504 Added 2.0%
25,668 $3.44 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $18,303 - $23,269
-133 Reduced 0.53%
25,164 $3.85 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $12,670 - $15,720
-96 Reduced 0.38%
25,297 $4.1 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $65,532 - $82,917
-610 Reduced 2.35%
25,393 $3.44 Million
Q3 2021

Oct 25, 2021

BUY
$106.4 - $120.78 $42,560 - $48,312
400 Added 1.56%
26,003 $2.8 Million
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $37,244 - $41,492
354 Added 1.4%
25,603 $2.88 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $282,041 - $310,493
-2,757 Reduced 9.84%
25,249 $2.73 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $15,615 - $21,081
194 Added 0.7%
28,006 $3 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $8,075 - $9,478
94 Added 0.34%
27,812 $2.44 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $18,709 - $25,035
255 Added 0.93%
27,718 $2.72 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $71,788 - $108,840
1,113 Added 4.22%
27,463 $2.09 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $17,239 - $21,569
239 Added 0.92%
26,350 $2.33 Million
Q3 2019

Nov 06, 2019

BUY
$62.98 - $75.72 $99,130 - $119,183
1,574 Added 6.41%
26,111 $1.98 Million
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $80,154 - $102,455
1,220 Added 5.23%
24,537 $1.78 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $16,893 - $19,883
219 Added 0.95%
23,317 $1.88 Million
Q4 2018

Feb 06, 2019

BUY
$77.85 - $96.01 $15,881 - $19,586
204 Added 0.89%
23,098 $2.13 Million
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $1,333 - $1,482
15 Added 0.07%
22,894 $2.17 Million
Q2 2018

Jul 18, 2018

SELL
$89.78 - $106.23 $35,642 - $42,173
-397 Reduced 1.71%
22,879 $2.12 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $103,143 - $138,118
-1,121 Reduced 4.59%
23,276 $2.2 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $93,231 - $102,236
-1,041 Reduced 4.09%
24,397 $2.36 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $1.78 Million - $2.27 Million
25,438
25,438 $2.26 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Shoker Investment Counsel, Inc. Portfolio

Follow Shoker Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shoker Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shoker Investment Counsel, Inc. with notifications on news.